已收盘 05-15 16:00:00 美东时间
-7.840
-5.17%
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
RBC Capital analyst Ken Herbert maintains Ducommun (NYSE:DCO) with a Outperform and raises the price target from $150 to $155.
05-13 23:46
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Ducommun业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 2026年第一季度营收达到2.09亿美元,同比增长9%,这是连续第四个季度营收超过2亿美元,也是连续第20个季度实现同比增长。其中商业航空航天业务营收8400万美元,同比增长18%;国防业务营收1.18亿美元,同比增长5%。 **盈利能力:** 毛利润5620万美元,毛利率26.9%;调整后EBITDA为3540万美元,占营收的16.9%;调整后营业收入1800万美元,占营收的8.6%。 **净利润:** GAAP净利润990万美元,每股收益0.64美
05-13 12:19
On Tuesday, Ducommun (NYSE:DCO) discussed first-quarter financial results durin...
05-13 02:01
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Ducommun (NYSE:DCO) reported quarterly earnings of $0.75 per share which missed the analyst consensus estimate of $0.78 by 3.85 percent. This is a 9.64 percent decrease over earnings of $0.83 per share from the same
05-12 18:01
Ducommun Incorporated announced that its Senior Vice President and Chief Financial Officer, Suman Mookerji, will participate in the 26th Annual B. Riley Securities Institutional Investor Conference on May 20, 2026. Institutional investors can arrange one-on-one meetings with management. Ducommun, founded in 1849, provides innovative products and manufacturing solutions to aerospace, defense, and industrial markets through its Electronic and Struc...
05-07 10:30
今日重点评级关注:Canaccord Genuity:维持Vertical Aerospace"买入"评级,目标价从9.5美元升至10.5美元;Canaccord Genuity:维持AtaiBeckley Inc."买入"评级,目标价从14美元升至15美元
04-21 11:25
Goldman Sachs analyst Noah Poponak maintains Ducommun (NYSE:DCO) with a Buy and raises the price target from $134 to $151.
04-21 01:46